COMMUNIQUÉS West-GlobeNewswire

Hormonic Unveils All-in-One Platform to Revolutionize Women’s Hormonal Health

31/10/2024 - 14:42

Hormonic offers personalized hormone health care through telehealth services and high-quality natural supplements, targeting root causes of imbalances Munich, Germany, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Hormonic is proud [...]

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain

31/10/2024 - 15:00

Company describes new biomarker and cognitive treatment effects that support continued development of pepinemab in Mild Cognitive Impairment and Mild Dementia due to Alzheimer’s disease ROCHESTER, N.Y., Oct. 31, 2024 ( [...]

AMN Healthcare Names Tomya Watt as Chief People Officer

31/10/2024 - 15:06

DALLAS, Oct. 31, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, today announced the appointment of Tomya Watt as Chief People [...]

Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

31/10/2024 - 15:32

First Phase 3 PDT study in patients with sBCC in the United States. Primary and secondary endpoints all highly statistically significant p<0.0001 Correlates to data seen in Europe where sBCC is already incorporated [...]

Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs

31/10/2024 - 15:54

Current timeline for drug development is 10-12 years and costs approximately $1-3 billion. Tevogen’s approach has the potential to shorten timelines and substantially reduce costs. Tevogen’s AI initiative, Tevogen.AI , [...]

Director/PDMR Shareholding

31/10/2024 - 17:00

DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support [...]

Monica Lewinsky Visits Agnivesh Agarwal’s Primeks Medical, Advocates Against Cyberbullying in Istanbul

31/10/2024 - 17:27

The internationally recognized cyberbullying activist partners with Primeks Medical in Istanbul during National Cybersecurity Awareness Month, bringing attention to critical social issues and supporting Turkey’s growing [...]

GUERBET : Calendrier financier de l'exercice 2025

31/10/2024 - 18:00

Calendrier financier de l’exercice 2025 Villepinte, le 31 octobre 2024 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, publie son calendrier financier [...]

GUERBET : Financial agenda for 2025

31/10/2024 - 18:00

Financial agenda for 2025 Villepinte, 31 October 2024 : Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2025. Publications [...]

KFSHRC Leads Ethical Integration of AI in Healthcare

31/10/2024 - 18:24

RIYADH, Saudi Arabia, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Responsible integration has become imperative as Artificial Intelligence (AI) continue to reshape the medical landscape. King Faisal Specialist Hospital & [...]

Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak

31/10/2024 - 19:22

Photo caption: Rwanda Minister of State for Health, Yvan Butera, was among those who received Sabin’s investigational vaccine in the open-label clinical trial. WASHINGTON, Oct. 31, 2024 (GLOBE NEWSWIRE) -- In continued [...]

HWH International Announces its Upcoming Launch of the Hapi Wealth Program

31/10/2024 - 19:40

Bethesda, MD, Oct. 31, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH” or the “Company”) (Nasdaq: HWH) is pleased to announce that the Company has scheduled the launch of Hapi Wealth, a program dedicated to [...]

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

31/10/2024 - 20:07

WOBURN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a [...]

Nearly 350 Patients Participate in the Foundation for Sarcoidosis Research Externally Led Patient-Focused Drug Development Meeting with the FDA

31/10/2024 - 20:28

CHICAGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- On October 28, 2024, the Foundation for Sarcoidosis Research (FSR) hosted a groundbreaking Externally Led Patient-Focused Drug Development (EL-PFDD) meeting on sarcoidosis with [...]

EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares

31/10/2024 - 21:00

WATERTOWN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with [...]

Lyell Immunopharma Completes Acquisition of ImmPACT Bio

31/10/2024 - 21:00

Acquisition strengthens Lyell’s clinical pipeline with the addition of IMPT-314, a dual-targeting CD19/CD20 CAR T-cell product candidate expected to initiate pivotal development in 2025 in patients in the 3 rd line [...]

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024

31/10/2024 - 21:01

Iovance also to Participate in Upcoming November Conferences SAN CARLOS, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing [...]

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

31/10/2024 - 21:01

License Provides Exclusive Commercialization Rights for US Distribution and Certain OUS Markets Agreement expected to boost NeuroOne sales revenue and profitability EDEN PRAIRIE, Minn., Oct. 31, 2024 (GLOBE NEWSWIRE [...]

Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update

31/10/2024 - 21:02

IBSRELA generates $40.6 million in net product sales revenue; Company expects full year 2024 IBSRELA net sales revenue to be between $145 and $150 million XPHOZAH generates $51.5 million in net product sales revenue [...]